Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleBudget Impact of Switching to Biosimilar Trastuzumab (CT-P6) for the Treatment of Breast Cancer and Gastric Cancer in 28 European Countries.AuthorsLee, Seung-Mi; Jung, Jae-Ho; Suh, David; Jung, Yu-Seon; Yoo, Seung-Lai; Kim, Dong-Won; Kim, Ji-An; Suh, Dong-ChurlPublicationBioDrugs, 2019, Vol 33, Issue 4, p423ISSN1173-8804Publication typeArticleDOI10.1007/s40259-019-00359-0